CHIVAX Trademark

Trademark Overview


On Friday, February 11, 2022, a trademark application was filed for CHIVAX with the United States Patent and Trademark Office. The USPTO has given the CHIVAX trademark a serial number of 97262974. The federal status of this trademark filing is REQUEST FOR SECOND EXTENSION - FILED as of Thursday, April 25, 2024. This trademark is owned by Virion Therapeutics, LLC. The CHIVAX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Vaccine platform, namely, vaccines used in the prevention and treatment of infectious diseases and cancers; pharmaceutical preparations with antiviral and anticancer properties for use in the treatment of adenovirus; vaccines for human use; human vaccine preparations; therapeutic vaccines for human use

Biomedical research services; research and development of vaccines and medicines; research, development, engineering and testing services in the fields of immuno pharmaceuticals and vaccines; scientific research; scientific research in the field of vaccines; clinical and pre-clinical development services in the nature of scientific research and conducting clinical trials for others in the fields of infectious diseases and cancers

General Information


Serial Number97262974
Word MarkCHIVAX
Filing DateFriday, February 11, 2022
Status719 - REQUEST FOR SECOND EXTENSION - FILED
Status DateThursday, April 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 2, 2023

Trademark Statements


Goods and ServicesVaccine platform, namely, vaccines used in the prevention and treatment of infectious diseases and cancers; pharmaceutical preparations with antiviral and anticancer properties for use in the treatment of adenovirus; vaccines for human use; human vaccine preparations; therapeutic vaccines for human use
Goods and ServicesBiomedical research services; research and development of vaccines and medicines; research, development, engineering and testing services in the fields of immuno pharmaceuticals and vaccines; scientific research; scientific research in the field of vaccines; clinical and pre-clinical development services in the nature of scientific research and conducting clinical trials for others in the fields of infectious diseases and cancers

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 16, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 29, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVirion Therapeutics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNewark, DE 19711

Party NameVirion Therapeutics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNewark, DE 19711

Trademark Events


Event DateEvent Description
Tuesday, February 15, 2022NEW APPLICATION ENTERED
Wednesday, February 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 28, 2022ASSIGNED TO EXAMINER
Tuesday, December 6, 2022NON-FINAL ACTION WRITTEN
Tuesday, December 6, 2022NON-FINAL ACTION E-MAILED
Tuesday, December 6, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 3, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 3, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, March 4, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 29, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 12, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 2, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 2, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 27, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 25, 2023SOU TEAS EXTENSION RECEIVED
Monday, September 25, 2023SOU EXTENSION 1 FILED
Monday, September 25, 2023SOU EXTENSION 1 GRANTED
Wednesday, September 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 25, 2024SOU TEAS EXTENSION RECEIVED
Thursday, April 25, 2024SOU EXTENSION 2 FILED
Thursday, April 25, 2024SOU EXTENSION 2 GRANTED
Friday, April 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 22, 2024SOU TEAS EXTENSION RECEIVED